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Molecular Pharmacology and Cell Biology, FMP, Berlin, GermanyABSTRACT GlialCAM, a glial cell adhesion molecule mutated in megalencephalic leukoencephalopathy with subcortical
cysts, targets the CLC-2 Cl- channel to cell contacts in glia and activates CLC-2 currents in vitro and in vivo. We found that
GlialCAM clusters all CLC channels at cell contacts in vitro and thus studied GlialCAM interaction with CLC channels to inves-
tigate the mechanism of functional activation. GlialCAM slowed deactivation kinetics of CLC-Ka/barttin channels and increased
CLC-0 currents opening the common gate and slowing its deactivation. No functional effect was seen for common gate deficient
CLC-0 mutants. Similarly, GlialCAM targets the common gate deficient CLC-2 mutant E211V/H816A to cell contacts, without
altering its function. Thus, GlialCAM is able to interact with all CLC channels tested, targeting them to cell junctions and
activating them by stabilizing the open configuration of the common gate. These results are important to better understand
the physiological role of GlialCAM/CLC-2 interaction.INTRODUCTIONGlialCAM, formerly called HepaCAM (1), is a cell adhe-
sion molecule primarily expressed in glia (2). GLIALCAM
is the second disease gene of MLC (3), a rare kind of leuko-
dystrophy characterized by early-onset macrocephaly and
myelin vacuolization (4). Interestingly, GlialCAM physi-
cally interacts with the gene product of MLC1, the first
gene found to be mutated in MLC (5). Both proteins co-
localize in junctions between astrocytes (3). Recently we
found that in astrocytes and oligodendrocytes, GlialCAM
is an auxiliary subunit of CLC-2, a rather ubiquitously ex-
pressed CLC Cl- channel (6). In mice, dysfunction of
CLC-2 leads to testicular and retinal degeneration and white
matter vacuolation (7). The latter phenotype provides a
mechanistic link of GlialCAM and CLC-2 functions in
glia. The hydrocephalus phenotype and the white matter
vacuolation suggest a disturbed water-homeostasis in the
brain of MLC patients (8,9). Strong support for a role of
CLC-2 in these homeostatic processes is provided by the
recent finding that loss of function mutations in CLC-2
lead to white matter edema in humans (9) and by recent
studies with Mlc1 and Glialcam knockout mice (10).
GlialCAM affects CLC-2 localization and it strongly
modulates its functional properties. With GlialCAM the
channel is clustered at cell contacts, especially at astro-Submitted April 7, 2014, and accepted for publication July 25, 2014.
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also in heterologous expression systems (6). Furthermore,
CLC-2 mediated currents are dramatically activated in het-
erologous expression systems. The typically slow activation
of the inward currents is highly accelerated and deactivation
is slowed. In Xenopus oocytes GlialCAM greatly amplifies
CLC-2 current levels and eliminates current rectification.
The effect of GlialCAM on the pH dependence of CLC-2
has led us to speculate that GlialCAM may activate the
‘‘common gate’’ of the channel (6). To obtain insight into
the mechanism of channel modulation by GlialCAM, we
wanted to test other Cl- channels as tools since the slow
gate mechanism is better understood in them.
A major open question regarding the association of Glial-
CAM with CLC-2 was if the dramatic activation of CLC-2
currents seen in heterologous expression systems is also
found in vivo. This question was answered recently by
Hoegg-Beiler et al. (10) who found that in vivo GlialCAM
is important for targeting MLC1 and CLC-2 to specialized
glial domains in vivo and that in particular in oligoden-
drocytes GlialCAM activates CLC-2 mediated currents
similarly to what is observed in heterologous expression
systems (6). Interestingly, no activation of CLC-2 currents
was observed in Bergmann glia (10). These data strongly
support the idea that not only the GlialCAM mediated tar-
geting of CLC-2 to specialized cell-cell junctions but also
the functional activation is physiologically relevant. How-
ever, the biophysical mechanisms underlying the activation
of CLC-2 by GlialCAM are currently unknown. Therefore
discerning the biophysical bases of the interaction betweenhttp://dx.doi.org/10.1016/j.bpj.2014.07.040
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derstand the functional and pathological role of GlialCAM.
In our previous work we showed that GlialCAM activates
a CLC-2 homolog from Drosophila, whose genome does not
contain a GlialCAM homolog, but that it does not alter the
currents mediated by CLC-5, a renal Cl-/Hþ exchanger (6).
In this study, we find that GlialCAM interacts in vitro with
all CLC channels studied including CLC-0, CLC-1, and
CLC-K/Barttin. We exploit these nonphysiological interac-
tions to prove that GlialCAM stabilizes the open conforma-
tion of the common gate, providing thus mechanistic insight
into the mechanism of activation of CLC-2 by GlialCAM.MATERIALS AND METHODS
Molecular biology
The channel constructs expressed in oocytes were in the pTLN vector. The
Barttin construct in the T3T7 vector and GlialCAM C-terminally tagged
with three flag epitopes in the pCSDest vector, as described in earlier
studies (6,11). For localization studies, rat CLC-2, human CLC-1, human
CLC-Ka, rat CLC-K1, Torpedo CLC-0, and human GlialCAM were tagged
with a GFP or with flag.
To create the self-cleavable 2A peptide (E2A) Barttin-CLC-K1 construct,
we use the following primers:
C term barttin E2A:
50caccgcatgttagcagacttcctctgccctctccactgccGCCTTGGGTGTCAGGCT
CAAAACCCAGCTCCTTTGCCGGG30
E2A N term CLC-K1: 50gtctgctaacatgcggtgacgtcgaggagaatcctggccca
ATGGAAGAACTCGTGGGACTGCGTGAGGGCTCCTCTGGG30
Fragments were amplified by PCR and cloned using gateway technology.Biochemical interaction assays
Biochemical interaction assay were performed using the split-TEV
(Tobacco etch virus protease), as described in Jeworutzki et al. (6).Electrophysiology with oocytes
Oocytes were obtained by surgery and collagenase treatment of ovaries
from Xenopus laevis frogs. Linearized cDNA was transcribed using the
Cell Script AmpliCap SP6 High Yield Message Maker Kit (CellScript,
Inc., Madison, WI) or the mMessage mMachine kit (Ambion, Life Technol-
ogies, Milan, Italy) and the constructs were expressed in oocytes by injec-
tion of 5 to 50 ng cRNA according to the expression level of the channel.
For GlialCAM, injecting 1.25 ng cRNA was sufficient to achieve the
maximal effect (6). To measure a possible increase in the currents by Glial-
CAM, we adapted the amount of injected channel RNA to maintain relative
small currents (<10 mA, to avoid problems of series resistance). Less-
diluted cRNA was injected for macro patch experiments to obtain an
adequate expression in on-cell patches. For the temperature experiments,
the CLC-0 cRNA was reduced when co-injected with GlialCAM together
to attain a similar expression level to exclude artifacts because of the
observed positive correlation of the offset currents and the amount of
expression of CLC-0 (12). Oocytes were kept in a solution containing (in
mM) 90 NaCl, 10 HEPES, 2 KCl, 1 MgCl2, 1 CaCl2, pH 7.5, for 2 to
3 days at 18C. Two electrode voltage-clamp was performed with a Turbo-
tec 03 amplifier (npi, Tamm, npi electronic, Germany) and the custom
acquisition program GePulse (freely available at http://users.ge.ibf.cnr.it/
pusch/programs-mik.htm). For CLC-1, CLC-2, and CLC-0 the bath solu-Biophysical Journal 107(5) 1105–1116tion contained (in mM) 100 NaCl, 5 MgSO4, and 10 HEPES/NaOH pH
7.3. The standard bath solution for CLC-Ka contained (in mM): 112
NaCl, 10 CaGluconate2, 1 MgSO4, and 10 HEPES pH 7.3. Unless otherwise
stated, measurements were performed at room temperature (z20C). For
measurements of the temperature dependence, the temperature of the
bath solution was controlled by a custom made temperature control system.
For macro patch experiments, the bath solution was (in mM) 100 mM
NMDG-Cl, 10 mM HEPES, 2 mM MgCl2, and 1mM EGTA pH 7.3 and
kept constantly at 25C. The pipette (extracellular) solution contained
100 mM NMDG (N-methyl-D-glucamine)-Cl, 10 mM MES and 5 mM
MgCl2 (pH 7.3). Boro- or aluminosilicate capillaries (Hilgenberg, Malsfeld,
Germany) were coated with Sylgard (Dow Corning Corporation, Midland,
MI) and fire-polished. The resistance was adjusted between 0.5 and 2 MU,
depending on the expression level of CLC-0.
The specificity of the chloride currents of every construct was tested by
replacing chloride with iodide (13,14).Electrophysiology with HEK 293 cells
Fluorescent Human embryonic kidney (HEK) 293 cells, expressing CLC-2-
GFP or the double mutant rCLC-2 E211V-H816A-GFP, both in the pFROG
vector þ/ GlialCAM, were measured with an extracellular solution con-
taining (in mM): 140 NaCl, 2 MgSO4, 2 CaCl2 and 10 HEPES/NaOH pH
7.3 using standard patch clamp technique. Intracellular solution was (in
mM) 130 NaCl, 2 MgSO4, 2 EGTA and 10 HEPES/NaOH pH 7.3. Only cells
for which currents were reversibly blocked by iodide were used for analysis.Voltage protocols and data analyses
To dissect hCLC-1 fast and slow gating we used two different protocols. In
the first protocol, the overall gating state was monitored using a ‘‘tail’’ pulse
to –100 mVafter prepulses to variable test voltages (Fig. S1 C and D in the
Supporting Material). In the second protocol, the tail pulse was preceded by
a short pulse to 180 mV that fully activated the fast gate without grossly
altering the slow gate (15) (Fig. 1 E and F). This procedure allowed us to
determine the open probabilities of the total currents (Fig. S1 E) and the
slow-gate mediated currents (Fig. 1 G) by describing the tail currents
with a Boltzmann function.
To estimate the constitutively activated currents of CLC-0 slow gating
voltage protocols were applied pulsing from 40 mV, were the fast gate is
fully open (16), to –120 mV followed by a tail pulse at 40 mV. From the
Boltzmann analysis of the tail currents, we obtained the relative open prob-
ability of the slow gate and the constitutive active currents, described by the
relative offset.
Deactivation kinetics of CLC-Ka currents in oocytes were analyzed by
fitting the decaying current, I(t), at 60 mV with a double exponential func-
tion of the following form:
IðtÞ ¼ a0 þ af  exp

-t

tf
þ as  expð-t=tsÞ;
where a0 is the steady state current, af the fast decaying component (time
constant tf), and as the slowly decaying component (time constant ts).
To study the temperature dependence and the block by 0.2 mM Zn2þ,
CLC-0 was maximally activated by a long pulse to –120 mV and then the
deactivation was followed by pulsing every 2 s to 40 mV while keeping
the channel at the resting potential (12).
To compare the currents of the CLC-2 and the double mutant CLC-2
E211V/H816A, oocytes or HEK293 cells were first pulsed to 60 mV to es-
timate the instantaneous activated current under resting conditions and then
activated with a long pulse to –140 mV. The following tail pulse to 60 mV
induced a very reproducible current deactivation, which can be best
described with a double exponential kinetics. The Imax of the tail pulse indi-
rectly reflects the expression level and the ratio Iss/Imax the preference of the
channel for the open configuration.
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FIGURE 1 Interaction of GlialCAM with
CLC-1. (A–D) Cellular distribution of CLC-1 in
HeLa cells. CLC-1 alone is located uniformly in
the plasma membrane and intracellularly (A, B)
whereas GlialCAM changes CLC-1 localization
when both proteins are co-transfected to regions
of direct contact (C, arrow) or to cell-cell contact
processes (D, arrow). (E–H) GlialCAM activates
the slow gate of CLC-1 (inset: protocol to deter-
mine the open probability of the slow gate; see
Methods). (E, F) typical currents from a patch
from oocytes expressing CLC-1 alone (E) or
CLC-1 with GlialCAM (F). (G) Initial (Io) tail cur-
rents from the patches shown were described with
a Boltzmann function (plus offset) and the open
probabilities of the example patches are plotted
against voltage. The relative offset of the slow
gate (H) is significantly larger with GlialCAM
(**p < 0.01, Student’s t-test, values are mean
5SE). Voltages of half-maximal activation were
not significantly different (data not shown). To
see this figure in color, go online.
GlialCAM Activates the Slow Gate of CLC Channels 1107Raw data were analyzed using a custom analysis program (Ana; freely
available at http://users.ge.ibf.cnr.it/pusch/programs-mik.htm), Excel
(Microsoft Corp., Redmond, WA), and Sigma Plot (Systat Software, Inc.,
San Jose, CA). To indicate statistical significance we depict mean values
5 SE and annotate p-values of Student’s t-test or of Bonferroni’s multiple
comparison test.RESULTS
GlialCAM interacts with CLC-1 and leads to CLC-1
clustering in cell-cell contacts
In our previous work we showed that GlialCAM strongly
clusters CLC-2 at cell-cell contacts (6). We tested whether
GlialCAM promotes a similar clustering of the muscle
CLC-1 channel. CLC-1 expressed alone in HeLa cells is de-
tected mostly all over the cell, especially around the nucleus
and on the cell surface (Fig. 1 A and B). When co-expressingGlialCAM, CLC-1 changes its localization pattern exten-
sively to the places of cells contacts largely overlapping
with the localization of GlialCAM (Fig. 1 C and D; marked
by arrows). A similar clustering of CLC-1 in cell-cell con-
tacts upon co-expression with GlialCAM was seen in
HEK 293 cells (data not shown). The biochemical interac-
tion was confirmed by Split TEV assay (Fig. S1 A and B).GlialCAM slightly increases the residual open
probability of CLC-1 channels in oocytes
To determine whether GlialCAM has a functional effect on
CLC-1 mediated currents, we co-expressed GlialCAM and
CLC-1 in Xenopus oocytes and performed inside-out patch
clamp recordings that allow a high-resolution quantitative
separation of fast and slow gating kinetics using two different
pulse protocols (15) (Figs. 1 E and F; and S1 C and D).Biophysical Journal 107(5) 1105–1116
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CLC-1 and CLC-1/GlialCAM (Fig. S1 E and F). In contrast,
for the slow gate, the residual activation at negative voltages
is significantly increased by GlialCAM co-expression
(Fig. 1 G and H). Thus, localization studies, biochemical
data, and functional expression demonstrate that CLC-1
and GlialCAM interact. However, the functional effect on
CLC-1 is rather small compared with the dramatic effects
seen for CLC-2 (6).GlialCAM slows deactivation of the CLC-Ka/
Barttin kidney Cl- channel
CLC-Ks belong to the CLC-1-like branch of plasma mem-
brane localized CLC Cl- channels (17). They share ~ 50%A
E F
B C
H I  
FIGURE 2 hCLC-Ka/Barttin mediated currents are modulated by GlialCAM
CLC-Ka and GlialCAM (B), CLC-Ka and Barttin (C), or CLC-Ka, Barttin, an
in the different co-injections. In (C) and (D) same scale bars as in (B). From th
in (E) and the steady state current (Iss), shown in (F) were determined. A doub
of the two exponential components (see Methods). Fast and slow time constants
GlialCAM 365 1 ms and 8.75 0.3 ms, respectively (n ¼ 10), i.e., not signific
exponential: the weight of the slow component is significantly increased by G
Cellular distribution of CLC-K1 in HeLa cells. Barttin-CLC-K1 alone is loc
GlialCAM leads to CLC-K1/barttin localization in regions of cell-cell contacts
Biophysical Journal 107(5) 1105–1116sequence identity with CLC-0, CLC-1, and CLC-2. Este´vez
et al. (18) showed that Barttin is a b-subunit of human
CLC-K channels necessary to target the channels to the
plasma membrane. Co-expression of CLC-Ka with Glial-
CAM without Barttin did not induce any currents different
from control oocytes (Fig. 2 B). Interestingly, the co-expres-
sion of all three proteins, CLC-Ka, Barttin, and GlialCAM
induces currents that are similar to CLC-Ka/Barttin, but
which exhibit markedly slower deactivation kinetics at
60 mV (Fig. 2 C, D, and G). Maximal (Fig. 2 E) or
steady-state currents (Fig. 2 F) at 60 mV were not different.
This modulation of the gating kinetics demonstrates that
CLC-Ka is able to interact simultaneously with Barttin
and with GlialCAM suggesting that the binding region is
different for both interaction partners.G
D
. (A) Pulse protocol. (B–D) Typical currents from oocytes injected with
d GlialCAM (D). Amount of cRNA for each construct was kept constant
e tail current after the –140 mV prepulse, the initial current (Imax), shown
le exponential fit to this tail current yielded time constants and coefficients
were for CLC-Ka/Barttin 435 11 ms and 6.85 1 ms, for CLC-Ka/Barttin/
antly different. (G) Ratio of slow (as) and fast coefficient (af) of the double
lialCAM. (***p < 0.001, Student’s t-test), values are mean 5 SE. (H–I)
ated uniformly in the plasma membrane and intracellularly (H) whereas
(I, arrow). To see this figure in color, go online.
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to cell contacts, initially CLC-Ka was co-transfected in
HEK cells either with only Barttin or GlialCAM or with
both subunits. Without GlialCAM, no clustering could be
observed (n ¼ 5 transfections, data not shown). In co-trans-
fections with GlialCAM (with and without Barttin), a few
cells could be observed that showed clustering at cell-cell
contacts (Fig. S2). This suggests that in principle Glial-
CAM is able to direct CLC-K channels to cell contacts,
even in the absence of Barttin, however with relatively
low efficiency. In particular, for the co-transfections
of CLC-Ka, Barttin, and GlialCAM, the low efficiency of
clustering could be attributable to a low probability to
have couples of adjacent cells that are both triple-trans-
fected. To overcome the latter difficulty, we created a Bart-
tin-CLC-K1 construct in which the two cDNAs were linked
by a self-cleavable 2A peptide. The 2A peptide mediates a
co-translational cleavage producing multiple proteins from
a poly-protein encoded by a single open reading frame (19).
HeLa cells were transfected with the construct alone (Fig. 2
H) or together with GlialCAM (Fig. 2 I). In the co-trans-
fected cells GlialCAM and CLC-K1 co-localize clearly at
the cell-cell contact.GlialCAM does not interact with the CLC-5
transporter
To determine if GlialCAM clustering is specific to CLC
channels, we tested whether GlialCAM promotes clustering
of the CLC-5 exchanger. CLC-5 expressed alone in HeLa
cells is detected mostly all over the cell cytoplasm (Fig. 3
A). When co-expressing GlialCAM, CLC-5 does not
change its cellular localization, with no clear co localization
at cell-cell contacts (Fig. 3 B). These data confirm our pre-
vious work, reporting that GlialCAM does not alter CLC-5
mediated currents (6). Thus GlialCAM is not able to
interact functionally or biochemically with the CLC-5
transporter.GlialCAM opens the slow gate of CLC-0
CLC-0 is a well-studied model channel that allows a rela-
tively easy distinction of fast and slow gating mechanisms
(12,16,20–29). To study if GlialCAM has some functional
effect on CLC-0, we used two electrode voltage clampand macro patch recordings of Xenopus oocytes. The fast
gate transients of CLC-0 þ/ GlialCAM did not show
any differences (Fig. S3).
The slow gate was studied by applying long voltage
pulses going from positive to negative voltages followed
by a tail pulse to 40 mV (Fig. 4 A). The slow gate starts to
increase its open probability at voltages more negative
than 60 mV that becomes visible at the positive tail pulse,
where the fast gate opens maximally (12) (Fig. 4 B and C).
CLC-0 co-expressed with GlialCAM exhibits a large consti-
tutive conductance at positive voltages and can only be
marginally further activated by hyperpolarization (Fig. 4
B, D, and E).
Comparing these tail currents of CLC-0 þ/ GlialCAM
(Fig. 4 B and C) shows that the residual open probability
is largely increased when GlialCAM is co-expressed
(Fig. 4 F). Also in macro patch on-cell experiments the rela-
tive offset of the slow gate was increased from ~ 0.2 without
GlialCAM to a value of ~ 0.6 when GlialCAM was co-ex-
pressed (Fig. S4).
When CLC-0-GFP was co-transfected with GlialCAM in
HEK293 cells, clusters at cell contacts were observed in 19
cell pairs of eight plated dishes (Fig. 4 G), demonstrating
physical interaction between the two proteins. To test if
the macroscopic functional effects on the slow gate repre-
sent the properties of a pure population of GlialCAM/
CLC-0 complexes, or a mixture of such complexes with
GlialCAM free CLC-0 dimers, we performed a titration
experiment in which we compared the properties of oocytes
injected with increasing amounts of GlialCAM RNA,
concentrating on the relative offset of the slow gate as a
functional readout (Fig. 4 H). In the experiment shown in
Fig. 4 H, the half-maximal effect of GlialCAM is seen at
an amount of 0.25 ng RNA per oocyte and saturation at
1 ng (Fig. 4 H). Thus, most likely, at the standard amount
used (2.5 ng) GlialCAM/CLC-0 complexes are the predom-
inant species. This conclusion is qualitatively in agreement
with the observation of a large percentage of clustering seen
in HEK cells. Nevertheless, from these experiments no
quantitative conclusion of interaction strength can be
drawn.
Taken together, GlialCAM is able to interact with
CLC-0, clustering the channel at cell contacts and favor-
ing the open conformation of the slow gate represented
by a large constitutive open probability, which isFIGURE 3 Co-expression of GlialCAM with
CLC-5 in HeLa cells. (A). Cellular distribution of
CLC-5 alone. (B). GlialCAM does not modify
CLC-5 localization when both proteins are co-
transfected. To see this figure in color, go online.
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FIGURE 4 GlialCAM activates the slow gate of
CLC-0. (A) Pulse protocol used to assay the slow
gate. (B, C) Typical current traces obtained with
this protocol for CLC-0 (B) and CLC-0/GlialCAM
(C). (D) Example tail currents from the current
traces shown in (B) and (C) plotted as a function
of the prepulse voltage and fitted with a Boltzmann
function with offset (lines). (E) Maximal current
at 40 mV obtained from the Boltzmann analysis
(F) Relative offset obtained from the Boltzmann
analysis (***p < 0.001, Student’s t-test). (G)
GlialCAM-induced clustering of CLC-0-GFP in
HEK293 cells. (H) Dose-response of increasing
concentration of GlialCAM on relative offset of
the slow gate. Amount of CLC-0 RNA was
0.25 ng/oocyte. Data were fitted by a ‘‘Boltzmann
equation’’ resulting in a half maximal amount of
0.25 ng/oocyte GlialCAM RNA (qualitatively
similar results were seen in a total of three batches
of oocytes). To see this figure in color, go online.
1110 Jeworutzki et al.similar, but much more dramatic, to what we observed for
CLC-1.Slow gate deactivation of CLC-0 / GlialCAM
channels remains temperature sensitive
Slow gating of CLC-0, and in particular its deactivation ki-
netics, is highly temperature sensitive with a Q10 of ~ 40
(12). To test if GlialCAM affects the temperature sensi-A B
FIGURE 5 Temperature sensitivity of the deactivation kinetics of the slow gate
to 40 mV, after a long hyperpolarizing pulse (T¼ 33C for this example). (B, C) C
the time constant (B) and the percentage of deactivation (C) as a function of tem
temperatures, it was not possible to obtain a reliable value for the time constan
batches; error bars represent SE).
Biophysical Journal 107(5) 1105–1116tivity we measured the deactivation kinetics of the slow
gate (12). After maximally activating the slow gate by re-
petitive hyperpolarization, the activation status of the slow
gate was monitored by short pulses to 40 mV, keeping the
oocytes at the resting voltage (Fig. 5 A; example traces at
33C). The deactivation kinetics were described by a single
exponential function, from which we obtain the time con-
stant, t, of the deactivation (Fig. 5 B) and the percentage
of deactivation (Fig. 5 C). The time constant is significantlyC
. (A) Current decay at resting conditions, monitored by brief pulses every 2 s
urrent deactivation was described by a single exponential function yielding
perature. Due to the very slow deactivation of CLC-0/GlialCAM at lower
t (n ¼ 4 to 7 for each temperature from a total of 5 to 10 different oocyte
GlialCAM Activates the Slow Gate of CLC Channels 1111larger and the percentage of deactivation significantly
smaller for CLC-0/GlialCAM compared with CLC-0 ex-
pressed alone. However, the temperature dependence is
comparable between CLC-0 and CLC-0/GlialCAM. Thus,
even though the open configuration of the slow gate in
the CLC-0/GlialCAM complex is stabilized dramatically,
it retains the characteristic temperature dependence of the
slow gate.CLC-0’s sensitivity to Zn2D inhibition is largely
reduced
CLC-0 inactivation was shown to be greatly facilitated by
extracellular Zn2þ (26). We found that the CLC-0/Glial-
CAM complex exhibits a very weak block by 0.2 mM
Zn2þ (Fig. 6 A). The percentage of block is more than
70% reduced for CLC-0/GlialCAM expressing oocytes
compared with CLC-0 alone (Fig. 6 B).CLC-0 open phenotype gating mutants do not
exhibit further activation by GlialCAM
The maximal current level of CLC-0 at 60 mV that is
achieved by saturating activation of the slow gate by repet-
itive hyperpolarization is roughly doubled by co-expression
with GlialCAM (Fig. 7 C, D, and I; p< 0.05). We wanted to
test if this current increase is additionally caused by a larger
number of channels present in the plasma membrane (with
GlialCAM), or if it only reflects a submaximal activation
of the slow gate by hyperpolarization (without GlialCAM).
To this end we employed gating mutants of CLC-0 that are
unlikely to disturb the biochemical interaction between the
two proteins, as being shown for CLC-2 mutants that abolish
the slow gate (see below; Fig. 8). Mutant C212S locks the
slow gate in the activated state (26). Further activated is
the double mutant C212S/E166C where the neutralization
of the gating glutamate constitutively activates the fast
gate and the slow gate (28,30). To study the constitutive
and maximally activatable current levels (for WT CLC-0)
we first applied short pulses to 60 mV without previous acti-
vation of the slow gate by hyperpolarization, followed by a
pulse to 160 mV for 200 ms. These pulses were appliedA Brepeatedly until there was no further current increase.
Fig. 7 C, E, and G present typical current traces of CLC-0
and the two mutants C212S and E166C/C212S. CLC-0 ex-
hibits around 50% of current activation by repetitive hyper-
polarization (Fig. 7 C and J). When co-expressed with
GlialCAM no significant further current increase could be
induced by negative voltages (Fig. 7 D and J). As expected,
for mutants C212S and C212S/E166C, no activation by
hyperpolarization is seen without or with GlialCAM
(Fig. 7 E–H and J).
More interestingly, the co-expression with GlialCAM did
not increase the maximal current level for these two mu-
tants, suggesting that GlialCAM does not increase the num-
ber of channels in the plasma membrane (Fig. 7 I).GlialCAM clusters CLC-2 ‘open-phenotype-
mutant’ E211V/H816A but currents are not
significantly changed
The double mutant E211V/H816A of CLC-2 where the
gating glutamate and a C-terminal histidine (31) are
mutated, results in a constitutive activation of the slow
gate in CLC-2 (32). Indeed, expressing this construct in
HEK293 cells or oocytes resulted in constitutively activated
channels as described (32) (Fig. 8 A and B). Co-expression
of this double-gating mutant with GlialCAM (Fig. 8 C and
D) leads to a slight increase of currents in oocytes (Fig. 8
D) but not in HEK cells (data not shown).
Importantly, GlialCAM has no effect on the biophysical
properties of the double mutant (Fig. 8 E). In HEK 293 cells,
co-expression of the E211V/H816A mutant with GlialCAM
leads to the clustering of the CLC-2 mutant in cell contacts,
demonstrating that the mutant does not interfere with the
biochemical interaction (Fig. 8 C).DISCUSSION
Combining the present and our previous study (6) shows that
GlialCAM is able to interact with all CLC channels tested so
far, i.e., mammalian CLC-1, CLC-2, and CLC-Ka,
Drosophila CLC-2 (dmCLC-2), and Torpedo CLC-0 (see
Table 1) for summary). The interaction of GlialCAM withFIGURE 6 GlialCAM reduces Zn2þ sensitivity
of CLC-0. (A) CLC-0 (closed circles) and CLC-
0/GlialCAM (open circles) were activated by a
long hyperpolarizing pulse and then deactivation
at the resting voltage was monitored by brief pulses
to 60 mV. 0.2 mM Zn2þ was applied at the indi-
cated time point. At the end of the experiment,
Cl- was replaced by iodide (gray arrow) to estimate
leak currents. (B) Percentage of block by 0.2 mM
Zn2þ of CLC-05 GlialCAM (nR 4 different oo-
cytes 5 SE each; ****p < 0.0001, Student’s
t-test).
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FIGURE 7 Effect of GlialCAM on currents of
CLC-0 gating mutants. (A) Voltage pulse that
was repetitively applied to maximally activate the
slow gate. (B) Currents from an uninjected control
oocyte. (C) Example traces from a CLC-0 express-
ing oocyte before and after maximal activation
of the slow gate. (D–H) Similar examples for
CLC-0þGlialCAM (D), C212S (E), C212Sþ
GlialCAM (F), E166C/C212S (G), and E166C/
C212SþGlialCAM (H). (I) Maximal currents of
the indicated constructs for one batch of oocytes,
similar results were seen in four batches (*p <
0.05, Bonferroni’s test). (J) Imin/Imax for the in-
dicated constructs, representing the ratio of the
currents at 60 mV before and after repetitive appli-
cation of the pulse shown in (A) (n > 6 oocytes for
each construct).
1112 Jeworutzki et al.CLC-1 and CLC-K is probably of no physiological rele-
vance because these two channels are not expressed in
glia. Even though it cannot be excluded that related proteins
could play similar roles in muscle, kidney, or inner ear, the
sites of expression of CLC-1 and CLC-K channels, the
closest homolog of GlialCAM, HepaCAM2, does not
interact with CLC-2 (6).Biophysical Journal 107(5) 1105–1116In all cases tested (CLC-1, CLC-2, CLC-K, Torpedo
CLC-0, and dmCLC-2) the interaction results in the cluster-
ing of the channels at cell-cell contacts, after the localization
of GlialCAM. This and the fact that most of the disease
inducing mutants of GlialCAM exhibit a disturbed clustering
phenotype strongly suggests that the precise localizationof the
interaction partners is physiologically very important (3,6).
A B C
D E
FIGURE 8 CLC-2 double gating mutant E211V/
H816A expressed in HEK cells and oocytes. (A, B)
Typical current traces obtained by a voltage pulse
to 60/–120/60 mV in oocytes (A) and HEK293 cells
(B) for the double mutant without (top) or with
(bottom) GlialCAM. (C) Fluorescence of HEK
cells expressing the E211V/H816A mutant
C-terminally fused to GFP without (top) or with
(bottom) GlialCAM. (D) Imax at 60 mV was
slightly increased for E211VH816A when co-ex-
pressing GlialCAM in oocytes (*p < 0.05, Bonfer-
roni’s test). Note, that in patch clamp experiments
of HEK cells GlialCAM does not increase the
currents of the double mutant. (E) In contrast to
CLC-2 co-expressing the double gating mutant
with GlialCAM does not alter its current character-
istics as assayed by the ratio of steady state currents
and Imax at 60 mV (nR 6 cells from two different
transfections/injections; error represents SEM). To
see this figure in color, go online.
GlialCAM Activates the Slow Gate of CLC Channels 1113On the other hand, GlialCAM does not interact with the
more distantly related CLC-5 transporter (this work and
(6)). Thus, the interaction with GlialCAM is less specific,
in comparison with the highly specific interaction of Barttin
with CLC-K channels (18) and of Ostm1 with the intracel-
lularly localized CLC-7 (33,34). The auxiliary subunit Bart-
tin is essential for efficient targeting and trafficking of the
CLC-K channels to the plasma membrane (18,35). Simi-
larly, it was shown also for GlialCAM that it stabilizes
MLC1 (36), the first identified GlialCAM binding partner
(3). Our previous observation that CLC-2 currents are
largely increased when GlialCAM is co-expressed (espe-
cially in oocytes) (6) might support the idea that GlialCAM
stabilizes also the CLC-2 protein in the plasma membrane
(by either increasing its insertion rate or by decreasing the
retrieval rate). Alternatively, the large current increase could
reflect a modulation of the gating of the channel, resulting in
an increased open probability.
In the Torpedo CLC-0 channel, the so-called fast gate or
protopore gate can close individual protopores and is funda-
mentally dependent on the so-called gating glutamate (E166
in CLC-0) (27,30,37). Additionally, both pores can besimultaneously switched off by a mechanism called slow
gate (38), because it acts in the seconds-to-minutes range,
whereas the fast gate opens and closes in the milliseconds
time range. The two gates of CLC-0 are not independent.
For example the CLC-0 mutants E166A or E166D not
only affect the fast gate but they also lock the slow gate in
an open configuration (28). Slow gating depends on pore oc-
cupancy because low external (16) and internal (39) [Cl-]
favor slow gate closure. However, the impressive tempera-
ture sensitivity of CLC-0 slow gating, with a Q10 of the
deactivation kinetics at positive voltages around 40, points
to a complex rearrangement of the channel (12). Also block
by Zn2þ is highly temperature sensitive and reflects a
closure of the slow gate (20). The CLC-0 mutant C212S
eliminates Zn2þ block and also locks the slow gate in an
open conformation (26).
A slow or common gate was also identified in CLC-1 and
CLC-2, which has however different quantitative properties
in these channels (32,40–48). In particular, fast and slow
gating have different voltage dependencies (40,49) and
slow gating is less temperature sensitive (47,50) in CLC-1
and CLC-2. Importantly, the key mutations of the gatingBiophysical Journal 107(5) 1105–1116
TABLE 1 Effect of GlialCAM on biophysical properties of
different CLC channels and transporters
Clustering
strength*
Increase
of Imax at
positive V
(in oocytes)
Activation
of slow
gatey
Slowed
kinetics of
deactivation
at positive
voltagesz
CLC-2 þþþ 15-fold þþþ þþþ
CLC-2E221V/H816A þþþ No - n.a.
CLC-1 þþþ No þ n.a.
CLC-0 þþ 3.9-fold þþþ þþþ
CLC-Ka þ No n.a. n.a.
CLC-KaþBarttin þ No n.a. þ
Barttin-2A-CLC-K1 þþ No n.a. þ
CLC-5 - No n.a. n.a.
*The strength of interaction is qualitatively indicated by the number of þ
signs reflecting the number of clusters found per number of transfected
dishes: CLC-2: 9/3; CLC-2E221V/H816A: 21/7; CLC-1: 28/8; CLC-0: 19/8;
CLC-Ka: 13/13; CLC-KaþBarttin: 9/13; Barttin-2A-CLC-K1: 9/4; CLC-
5: 0/3. ythe number of þ signs qualitatively indicates that the slow gate is
strongly activated in CLC-0 and CLC-2 but only slightly in CLC-1; zthe
number of þ signs qualitatively indicates that the deactivation kinetics is
strongly affected in CLC-2 and CLC-0 and less in CLC-Ka. n.a.: not appli-
cable.
1114 Jeworutzki et al.glutamate and the cysteine corresponding to C212 of CLC-0
drastically affect slow gating also in CLC-1 and CLC-2
(15,47). Interestingly, slow gating is dependent on the cyto-
solic C terminus of the channels that contains two so-called
CBS domains (31,32,48,51,52), and that have been pro-
posed to undergo a large conformational change during
slow gating transitions (53,54).
Even less understood are the gating mechanisms of
CLC-K channels, which are associated with the small Bart-
tin subunit. Even though the ‘‘gating glutamate’’ is replaced
by a valine in CLC-K channels, they undergo time- and
voltage-dependent relaxations, in particular when expressed
in Xenopus oocytes (11,18). At the single-channel level
CLC-K channels exhibit a double-barreled appearance
(55). However, the relationship of the mechanisms underly-
ing CLC-K gating with those of CLC-0, CLC-1, and CLC-2
is still not clear.
Here we exploited the interaction of GlialCAMwith other
CLC channels to investigate the biophysical mechanisms
underlying the strong activation of CLC-2 mediated currents
by GlialCAM.
Although functional effects on CLC-1 were rather subtle,
we could verify a dramatic activation of CLC-0, caused by
an increase of the open probability of the slow (common)
gate of the channel. Several lines of evidence, including
two-electrode voltage clamp measurements, patch-clamp
recordings, investigation of temperature dependence and
Zn2þ block, and the investigation of slow gate deficient mu-
tants, point to the same conclusion: in the protein complex
CLC-0/GlialCAM the open conformation of the slow gate
is significantly stabilized compared with CLC-0 alone. In
contrast, the number of channels expressed in the plasmaBiophysical Journal 107(5) 1105–1116membrane is not significantly increased by GlialCAM. It
is thus natural to make the same conclusion regarding the
functional effect of GlialCAM on CLC-2, even though the
slow gate is less well defined for CLC-2. Strong evidence
in support for the conclusion that GlialCAM activates the
common gate also for CLC-2 was obtained by investigation
of the interaction of GlialCAM with the CLC-2 mutant
E211V/H816A in which the common gate is locked open
(32): although GlialCAM targets the mutant to cell-contacts
just as WT, it has almost no effect on the current magnitude
in oocytes or in HEK cells.
Thus, taken together, we can conclude that, in general,
GlialCAM interaction results mainly in a stabilization of
the open configuration of the common gate of CLC-chan-
nels. Thus, the future identification of the interaction sites
of CLC channels with GlialCAM might be helpful to gain
insight into the mechanisms underlying the slow gate, which
is still poorly understood.
A somewhat unexpected result is that GlialCAM is able to
interact with CLC-K/Barttin channels, although it cannot
substitute for Barttin. The interaction of CLC-Ka/Barttin
with GlialCAM results in a slowed deactivation of currents
at positive voltages. This suggests that the gating kinetics of
CLC-K channels reflect relaxations of the common gate in
agreement with other studies (55,56). In addition, this result
shows that CLC-Ka, Barttin, and GlialCAM are able to form
a heteromeric complex (of unknown stoichiometry) and thus
that Barttin (a 2 trans membrane domain (TMD) protein)
and GlialCAM (a 1 TMD protein) interaction sites with
CLC-Ka do not significantly overlap. It will be interesting
to dissect the interaction sites of these three proteins.
The properties of CLC-2 are highly dependent on the
expression system (39,46,49,57,58), and also the increase
of currents caused by GlialCAM is less pronounced in
HEK cells than in Xenopus oocytes (6). These differences
might be caused by various mechanisms, including different
posttranslational modification (e.g., glycosylation (59)),
different modes of interaction involving cytosolic domains
of the proteins (e.g., the CLC-2 N-terminus (13,46,57)) or
interactions with the cytoskeleton (60). Recently (10) the
functional network of MLC1, GlialCAM, and CLC-2 and
its role in leukodystrophy was investigated in vivo, by study-
ing mice that lack MLC1, CLC-2, or GlialCAM. As ex-
pected, loss of GlialCAM changes the localization and
abundance of CLC-2 and MLC1 in glia. Interestingly, acti-
vation of CLC-2 currents by GlialCAM was clearly
observed in oligodendrocytes but not in Bergmann glia
(10). This in vivo study positively answers the question
whether the functional effect of GlialCAM on CLC-2 occurs
also in a physiological setting, even though the selective
activation in oligodendrocytes remains mysterious.
In this respect, it is important to investigate the biophys-
ical mechanisms underlying the activation of CLC-2 medi-
ated currents by GlialCAM. In this study, using as a tool the
interaction of GlialCAM with other CLC channels, we
GlialCAM Activates the Slow Gate of CLC Channels 1115obtained significant insight into these mechanisms. We
showed that GlialCAM is able to interact with all tested
CLC channels (CLC-0, CLC-1, CLC-2, dmCLC-2, and
CLC-K/Barttin) even though, except for CLC-2, there is
no physiological role of this interaction. Our data strongly
suggest that GlialCAM stabilizes the open conformation
of the common gate, providing thus mechanistic insight
into the mechanism of activation of CLC-2 by GlialCAM.SUPPORTING MATERIAL
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